J

JF Tremblay

Peptide Researcher & Biochemist

Exercise Physiology & Biochemistry (UQAM)Owner, CanLab30+ Years Peptide Research

Thirty years in peptide research and manufacturing, and he runs his own lab. JF Tremblay (CanLab) brings a biochemist's precision to anti-aging protocols. His Epithalon approach breaks from the standard Khavinson protocol: 100mg total spread over 20-30 days instead of the typical 50mg over 10 days. He appeared on Ben Greenfield's peptides podcast and Nathalie Niddam's show with detailed dosing rationale. His BPC-157 dual-dose strategy (10mg monthly high-dose pulse or 250mcg daily short cycles) gives users two distinct options based on their comfort level.

anti agingbiochemistrypeptide manufacturinglongevity

Source Timeline

All verified sources where JF discussed peptide protocols.

PodcastJan 2021

BPC-157 oral vs injectable, dual-dose rationale

PodcastJan 2020

Full anti-aging stack with Epithalon long-cycle dosing and BPC-157 dual-dose strategy

Protocols shown here are based on publicly disclosed information from JF Tremblay. They are reproduced for educational purposes only and are not endorsements. Always consult a healthcare provider before starting any peptide protocol.

Not medical advice. Talk to your provider before using any peptide.

Full disclaimer